Ann: Market Update, page-7

It's normal skincare business is quite good as a standalone, so the latest foray into medicinal cannabis is a terrific addition. I bought this company after the IPO and have been keen to see how they are going to grow what has been essentially a sales and distribution business.

The selling point for the business was the sales and distribution ability and with such a low market capitalisation, I felt that it was a fair punt to take for me.